Target-Activated Prodrugs (TAPs) for the Autoregulated Inhibition of MMP12.

about

Airway mucus obstruction triggers macrophage activation and matrix metalloproteinase 12-dependent emphysema.Controlled release strategy of paclitaxel by conjugating to matrix metalloproteinases-2 sensitive peptide.Recent developments of genetically encoded optical sensors for cell biology.

P2860

Q34419996-EEB83D57-280A-4869-9ECA-20EACE66D1E5 Q37588432-D64918A4-CB43-42B1-AE84-BBF8A3914F59 Q38821204-0448D26B-731B-4434-94A8-739BD8F77F5F

P2860

Target-Activated Prodrugs (TAPs) for the Autoregulated Inhibition of MMP12.

Item

http://www.wikidata.org/entity/Q39573243

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Target-Activated Prodrugs (TAPs) for the Autoregulated Inhibition of MMP12.

@en

Target-Activated Prodrugs

@nl

type

Item

label

Target-Activated Prodrugs (TAPs) for the Autoregulated Inhibition of MMP12.

@en

Target-Activated Prodrugs

@nl

prefLabel

Target-Activated Prodrugs (TAPs) for the Autoregulated Inhibition of MMP12.

@en

Target-Activated Prodrugs

@nl

P1476

Target-Activated Prodrugs (TAPs) for the Autoregulated Inhibition of MMP12

@en

P2093

Amanda Cobos-Correa

http://www.w3.org/2001/XMLSchema#string

P2860

Biotin-tagged probes for MMP expression and activation: design, synthesis, and binding properties

Design and therapeutic application of matrix metalloproteinase inhibitors

Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

Development of selective inhibitors and substrate of matrix metalloproteinase-12.

Inhibitor fingerprinting of matrix metalloproteases using a combinatorial peptide hydroxamate library.

Zinc-binding groups modulate selective inhibition of MMPs.

The design, structure, and therapeutic application of matrix metalloproteinase inhibitors.

Targeting proteases: successes, failures and future prospects.

Automated Lead Optimization of MMP-12 Inhibitors Using a Genetic Algorithm.

P304

653-657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ML3001193

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carsten Schultz

Frank Stein

P577

2012-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

251571323

http://www.w3.org/2001/XMLSchema#string

P698

24900526

http://www.w3.org/2001/XMLSchema#string

P932

4025753

http://www.w3.org/2001/XMLSchema#string

Target-Activated Prodrugs (TAPs) for the Autoregulated Inhibition of MMP12.

about

P2860

P2860

Target-Activated Prodrugs (TAPs) for the Autoregulated Inhibition of MMP12.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932